Novo Nordisk's ad campaign, which aimed to speak ‘without filters’ by declaring obesity a disease, has faced strong criticism on social media and from some scientific societies
21
votes
-
-
Novo Nordisk rebuked by UK watchdog over failure to disclose payments to health groups – Danish drug giant found to have failed to accurately report spending even after admitting to errors
13 votes -
Novo Nordisk is to invest more than $4bn in US manufacturing as it battles to keep up with booming demand for its obesity and diabetes drugs Wegovy and Ozempic
9 votes -
Novo Nordisk suggested to senior UK government officials that they could “profile” benefit claimants – those who are most likely to return to the labour market
17 votes -
The ‘breakthrough’ obesity drugs that have stunned researchers
17 votes